On March 4, 2022, the Department of Defense (DoD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a maximum $565.8 million contract to Cepheid, located in Sunnyvale, California. The award includes the company's multiplex point-of-care nucleic acid amplification tests (Xpert® Xpress SARS-CoV-2/Flu/RSV) and analyzers (GeneXpert® Xpress IV) for influenza A, influenza B, Respiratory Syncytial Virus, and SARS-CoV-2, the virus that causes COVID-19.   back...